vs

Side-by-side financial comparison of HEALTHCARE SERVICES GROUP INC (HCSG) and INNOVATE Corp. (VATE). Click either name above to swap in a different company.

HEALTHCARE SERVICES GROUP INC is the larger business by last-quarter revenue ($466.7M vs $382.7M, roughly 1.2× INNOVATE Corp.). On growth, INNOVATE Corp. posted the faster year-over-year revenue change (61.7% vs 6.6%). Over the past eight quarters, INNOVATE Corp.'s revenue compounded faster (10.2% CAGR vs 5.0%).

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

Innovate Corp. is an American public financial services company founded in 1994.

HCSG vs VATE — Head-to-Head

Bigger by revenue
HCSG
HCSG
1.2× larger
HCSG
$466.7M
$382.7M
VATE
Growing faster (revenue YoY)
VATE
VATE
+55.2% gap
VATE
61.7%
6.6%
HCSG
Faster 2-yr revenue CAGR
VATE
VATE
Annualised
VATE
10.2%
5.0%
HCSG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCSG
HCSG
VATE
VATE
Revenue
$466.7M
$382.7M
Net Profit
$-7.4M
Gross Margin
15.4%
15.4%
Operating Margin
6.1%
3.7%
Net Margin
-1.9%
Revenue YoY
6.6%
61.7%
Net Profit YoY
55.4%
EPS (diluted)
$0.43
$-0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCSG
HCSG
VATE
VATE
Q4 25
$466.7M
$382.7M
Q3 25
$464.3M
$347.1M
Q2 25
$458.5M
$242.0M
Q1 25
$447.7M
$274.2M
Q4 24
$437.8M
$236.6M
Q3 24
$428.1M
$242.2M
Q2 24
$426.3M
$313.1M
Q1 24
$423.4M
$315.2M
Net Profit
HCSG
HCSG
VATE
VATE
Q4 25
$-7.4M
Q3 25
$43.0M
$-8.9M
Q2 25
$-32.4M
$-19.8M
Q1 25
$17.2M
$-24.5M
Q4 24
$-16.6M
Q3 24
$14.0M
$-15.0M
Q2 24
$-1.8M
$14.4M
Q1 24
$15.3M
$-17.4M
Gross Margin
HCSG
HCSG
VATE
VATE
Q4 25
15.4%
15.4%
Q3 25
20.8%
14.3%
Q2 25
0.6%
18.8%
Q1 25
15.2%
16.6%
Q4 24
13.4%
19.6%
Q3 24
14.8%
19.9%
Q2 24
9.7%
21.0%
Q1 24
15.2%
15.4%
Operating Margin
HCSG
HCSG
VATE
VATE
Q4 25
6.1%
3.7%
Q3 25
12.3%
1.8%
Q2 25
-9.1%
2.0%
Q1 25
5.3%
1.2%
Q4 24
3.4%
1.1%
Q3 24
4.4%
2.4%
Q2 24
-0.5%
9.2%
Q1 24
5.0%
0.9%
Net Margin
HCSG
HCSG
VATE
VATE
Q4 25
-1.9%
Q3 25
9.3%
-2.6%
Q2 25
-7.1%
-8.2%
Q1 25
3.8%
-8.9%
Q4 24
-7.0%
Q3 24
3.3%
-6.2%
Q2 24
-0.4%
4.6%
Q1 24
3.6%
-5.5%
EPS (diluted)
HCSG
HCSG
VATE
VATE
Q4 25
$0.43
$-0.57
Q3 25
$0.59
$-0.71
Q2 25
$-0.44
$-1.67
Q1 25
$0.23
$-1.89
Q4 24
$0.15
$-0.72
Q3 24
$0.19
$-1.18
Q2 24
$-0.02
$1.03
Q1 24
$0.21
$-2.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCSG
HCSG
VATE
VATE
Cash + ST InvestmentsLiquidity on hand
$168.0M
$112.1M
Total DebtLower is stronger
$80.3M
Stockholders' EquityBook value
$510.2M
$-240.1M
Total Assets
$794.3M
$950.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCSG
HCSG
VATE
VATE
Q4 25
$168.0M
$112.1M
Q3 25
$177.5M
$35.5M
Q2 25
$134.5M
$33.4M
Q1 25
$114.8M
$33.3M
Q4 24
$107.3M
$48.8M
Q3 24
$103.8M
$51.0M
Q2 24
$105.6M
$80.2M
Q1 24
$104.9M
$38.4M
Total Debt
HCSG
HCSG
VATE
VATE
Q4 25
$80.3M
Q3 25
$97.3M
Q2 25
$160.1M
Q1 25
$139.9M
Q4 24
$500.6M
Q3 24
$502.4M
Q2 24
$638.3M
Q1 24
$641.5M
Stockholders' Equity
HCSG
HCSG
VATE
VATE
Q4 25
$510.2M
$-240.1M
Q3 25
$496.0M
$-233.3M
Q2 25
$477.0M
$-224.8M
Q1 25
$514.2M
$-204.2M
Q4 24
$499.9M
$-180.4M
Q3 24
$488.7M
$-163.1M
Q2 24
$471.4M
$-149.0M
Q1 24
$474.6M
$-184.4M
Total Assets
HCSG
HCSG
VATE
VATE
Q4 25
$794.3M
$950.1M
Q3 25
$804.3M
$913.2M
Q2 25
$802.2M
$890.9M
Q1 25
$823.0M
$868.0M
Q4 24
$802.8M
$891.1M
Q3 24
$805.8M
$897.2M
Q2 24
$799.7M
$898.9M
Q1 24
$803.9M
$943.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCSG
HCSG
VATE
VATE
Operating Cash FlowLast quarter
$17.4M
$101.1M
Free Cash FlowOCF − Capex
$16.0M
FCF MarginFCF / Revenue
3.4%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$139.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCSG
HCSG
VATE
VATE
Q4 25
$17.4M
$101.1M
Q3 25
$71.3M
$19.2M
Q2 25
$28.8M
$40.4M
Q1 25
$27.5M
$-14.1M
Q4 24
$36.2M
$41.4M
Q3 24
$4.3M
$-28.4M
Q2 24
$16.3M
$21.5M
Q1 24
$-26.0M
$-25.4M
Free Cash Flow
HCSG
HCSG
VATE
VATE
Q4 25
$16.0M
Q3 25
$70.0M
$19.0M
Q2 25
$27.4M
Q1 25
$25.8M
$-18.8M
Q4 24
$34.8M
$34.2M
Q3 24
$2.9M
$-31.5M
Q2 24
$15.0M
$18.4M
Q1 24
$-28.2M
$-31.0M
FCF Margin
HCSG
HCSG
VATE
VATE
Q4 25
3.4%
Q3 25
15.1%
5.5%
Q2 25
6.0%
Q1 25
5.8%
-6.9%
Q4 24
7.9%
14.5%
Q3 24
0.7%
-13.0%
Q2 24
3.5%
5.9%
Q1 24
-6.7%
-9.8%
Capex Intensity
HCSG
HCSG
VATE
VATE
Q4 25
0.3%
Q3 25
0.3%
0.1%
Q2 25
0.3%
Q1 25
0.4%
1.7%
Q4 24
0.3%
3.0%
Q3 24
0.3%
1.3%
Q2 24
0.3%
1.0%
Q1 24
0.5%
1.8%
Cash Conversion
HCSG
HCSG
VATE
VATE
Q4 25
Q3 25
1.66×
Q2 25
Q1 25
1.60×
Q4 24
Q3 24
0.31×
Q2 24
1.49×
Q1 24
-1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCSG
HCSG

Dietary Services$255.9M55%
Other$210.8M45%

VATE
VATE

Commercial Revenue$126.1M33%
Industrial Revenue$87.5M23%
Transportation Revenue$58.4M15%
Healthcare Revenue$48.4M13%
Government Revenue$44.3M12%
Energy Revenue$8.0M2%
Broadcast Station Revenue$5.7M1%
Systems And Consumables Revenue$3.1M1%
Leisure Revenue$200.0K0%

Related Comparisons